Responding to an Arnold Ventures-backed opinion piece in the New England Journal of Medicine attacking tax-exempt hospitals and the 340B program, AHA General Counsel and Secretary Melinda Hatton says the authors’ disclosure form speaks volumes. “Specifically, that it is influenced by a shadowy organization with an obvious bias against hospitals. This article should be understood for what it is: just another attempt by a deep-pocketed organization with a biased agenda to attack hospitals.” READ MORE

Related News Articles

Headline
The Department of Health and Human Services Feb. 5 in a court filing said it would scrap its current 340B Rebate Model Pilot Program and potentially restart…
Headline
A new AHA blog published Feb. 3 discusses how the 340B Drug Pricing Program serves as an effective solution to some of the nation’s most persistent and…
Blog
Public
Many Americans may be unaware that the services they rely on every day through their local hospital are supported by a program called the 340B Drug Pricing…
Headline
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…
Headline
The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate…
Headline
The 1st U.S. Circuit Court of Appeals Jan. 7 denied the government’s motion for a stay in a lawsuit filed by the AHA, the Maine Hospital Association and four…